Home › Trials › NCT07864870
Clinical trial Recruiting at 1 site Observational Ages 18 and up

Strasbourg pST soft tissue sarcoma care patterns and survival

Official title: Sarcoma Adherence to Good Practice and Effect on Survival: A Retrospective Monocentric Study

Run by University Hospital, Strasbourg, France · NCT07864870 · Data updated 2026-11-12

This study looks back at how closely soft tissue sarcoma care in Strasbourg followed international guidelines and whether that related to overall survival, comparing patient care from 2010-2016 to 2017-2024.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment900 (estimated)
SponsorUniversity Hospital, Strasbourg, France
Academic / other
Locations1 site (Strasbourg)
StatusRecruiting
StartedNovember 27, 2025
Main results expectedJanuary 27, 2027
Study endsMarch 27, 2027
Registry record updatedOctober 8, 2026
Trial IDNCT07864870 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) with soft tissue or visceral sarcoma evaluated at the Strasbourg multidisciplinary tumor board between 2017 and 2024, with consent for data reuse.

Probably not a fit

Patients whose care diverged from guidelines or who have poor prognosis unrelated to treatment adherence may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a retrospective, single-center observational study conducted at the University Hospital of Strasbourg. It examines adherence to international clinical practice guidelines for soft tissue sarcoma management and explores how adherence relates to overall survival. The analysis compares two time periods, 2010-2016 and 2017-2024, using cases presented at the multidisciplinary tumor board. Inclusion focuses on adults (18+) first seen between 2017 and 2024 with available data and consent for research reuse of records. Exclusions remove younger patients, non-soft-tissue tumors, outside Alsace-Moselle, or duplicate records.

Why it matters

Potential benefit: Findings could clarify whether guideline-adherent care is associated with better survival for STS patients in this region.

How similar studies have gone: Similar observational studies have linked guideline adherence to better outcomes in sarcoma care, though results vary by setting.

Who can join: the full rules

Show full inclusion / exclusion criteria 
Inclusion Criteria:

* Patient aged 18 years or older at first multidisciplinary tumor board presentation
* Presented for multidisciplinary tumor board evaluation for soft tissue or visceral tumor
* First presentation between 01/01/2017 and 31/12/2024
* Absence of opposition to reuse of medical data for research purposes

Exclusion Criteria:

* Presence of opposition to reuse of medical data for research purposes
* Patient younger than 18 years at first presentation
* Bone tumors, gastrointestinal stromal tumors (GIST), or Kaposi sarcoma
* First presentation outside the study period
* Management outside Alsace-Moselle
* Duplicate records

Where it's running

  • Service d'hématologie-oncologie pédiatrique - CHU de Strasbourg - France
    Strasbourg, France     Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov ↗ Find more trials like this →
Browse more
Soft Tissue Sarcoma (STS) 18University Hospital, Strasbourg, France 195
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.